Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SHE:301096)
China flag China · Delayed Price · Currency is CNY
38.64
+0.86 (2.28%)
Nov 17, 2026, 4:00 PM EST

SHE:301096 Revenue

Hangzhou Bio-Sincerity Pharma-Tech had revenue of 145.40M CNY in the quarter ending September 30, 2026, a decrease of -18.10%. This brings the company's total for the last twelve months to 617.95M, up 4.68% year-over-year. In the year 2025, Hangzhou Bio-Sincerity Pharma-Tech had annual revenue of 677.99M, down -15.45%. That makes Hangzhou Bio-Sincerity Pharma-Tech the 23,292nd largest company in the world by revenue and 4,200th in China.

Revenue (ttm)
617.95M
Revenue Growth
+4.68%
P/S Ratio
6.78
Revenue / Employee
437.64K
Employees
1,412
Market Cap
4.19B

Revenue Chart

Revenue by Geography

  • China 677.54M 99.9%
  • Overseas 446.33K 0.1%
Fiscal year ended Dec 31, 2025 See the full SHE:301096 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025677.99M-123.94M-15.45%
Dec 31, 2024801.92M-215.52M-21.18%
Dec 31, 20231.02B410.04M67.51%
Jan 1, 2023607.41M233.10M62.27%
Dec 31, 2021374.31M167.06M80.61%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.